Transaction · 0001061983-26-000013

Callos Andrew

Callos Andrew, EVP, CCO, reported an open-market or private sale at CYTOKINETICS INC involving 886.000000 shares for an estimated $54595.32. Reported holdings after the transaction were 50440.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SEVP, CCO
CYTKCYTOKINETICS INC
Filing timeMar 02
Trade dateMar 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$61.43
Pre-filing
1mo ago +2.9%1w ago +11.1%1d ago +1.3%
Returns since
7d +1.6%30d +8.4%90d +25.0%180d +27.3%1y +27.3%

CYTK price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CYTK since 2026-03-02Filed 186 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001061983-26-000013
Common Stock
Transaction date
Mar 02, 2026
Filed Mar 02, 2026, 12:00 AM · 0d delay
Shares
886 sh
$6.16k per share
Estimated value
-$5.45M
Computed from shares × price
Holdings after
50.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Repeat Seller
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Commercial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.

Original filing · 0001061983-26-000013
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CYTK